4-(2,5-Dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic Anhydride>97.0%(HPLC)(T)25g

4-(4-Nitrophenyl)morpholine, 95.0%, 10g

4-(4-Morpholinopiperidin-1-yl)aniline, 95%, 100mg

4-Bromo-2-tert-butylaniline, 98.0%, 1g

DIETHYL 2-CHLOROBENZYLPHOSPHONATE, 95.0%, 10g

(R)-2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-dicarboxaldehyde, 97%, 5g

N-Phenyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)naphthalen-1-amine, 98%, 1g

Vial de reacción con brida plana, cilíndrico, graduado, con camisa atemperada pieza de conexión GL, DN 60, 500 ml, 90 mm, 1 pieza

alpha-Phenyl-trans-cinnamic acid, 95.0%, 100g

2-amino-6-ethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-ol, 95.0%, 5g

METHYL 1H-PYRAZOLO[3,4-B]PYRIDINE-3-CARBOXYLATE, 95%, 250mg

{8-methyl-1,4-dioxaspiro[4.5]decan-8-yl}methanol, 98%, 100mg

ETHYL 3-AMINO-3-(3-HYDROXYPHENYL)PROPANOATE, 95.0%, 5g